AU2003300462A1 - Method for detecting and limiting breast carcinoma risk by a micronucleus test of binuclear cells - Google Patents

Method for detecting and limiting breast carcinoma risk by a micronucleus test of binuclear cells

Info

Publication number
AU2003300462A1
AU2003300462A1 AU2003300462A AU2003300462A AU2003300462A1 AU 2003300462 A1 AU2003300462 A1 AU 2003300462A1 AU 2003300462 A AU2003300462 A AU 2003300462A AU 2003300462 A AU2003300462 A AU 2003300462A AU 2003300462 A1 AU2003300462 A1 AU 2003300462A1
Authority
AU
Australia
Prior art keywords
determining
risk
hours
culture
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300462A
Other versions
AU2003300462A8 (en
Inventor
Walther Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003300462A8 publication Critical patent/AU2003300462A8/en
Publication of AU2003300462A1 publication Critical patent/AU2003300462A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Determining the risk of developing breast cancer based on spontaneous development of micronuclei in mitogen-treated lymphocyte cultures, is new. Method for determining the risk of developing breast cancer comprising: (a) establishing a lymphocyte culture from heparin-treated peripheral blood; (b) mitogenic stimulation within 6 hours of establishing the culture; (c) adding a cytokinesis inhibitor 40-50 hours after establishment; (d) interrupting culture 12-24 hours after (c) by centrifuging, hypotonic treatment then preparation of a fixed cell suspension; (e) making a cytological preparation; (f) determining the micronucleus rate (MNR) in binuclear cells; and (g) determining the risk by comparing spontaneous MNR in the test sample with that in controls.
AU2003300462A 2002-10-08 2003-10-08 Method for detecting and limiting breast carcinoma risk by a micronucleus test of binuclear cells Abandoned AU2003300462A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10246811A DE10246811B4 (en) 2002-10-08 2002-10-08 Method for detecting and limiting the risk of breast cancer by the micronucleus test on binucleated cells
DE10246811.7 2002-10-08
PCT/EP2003/011141 WO2004034055A2 (en) 2002-10-08 2003-10-08 Method for detecting and limiting breast carcinoma risk by a micronucleus test of binuclear cells

Publications (2)

Publication Number Publication Date
AU2003300462A8 AU2003300462A8 (en) 2004-05-04
AU2003300462A1 true AU2003300462A1 (en) 2004-05-04

Family

ID=32038312

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300462A Abandoned AU2003300462A1 (en) 2002-10-08 2003-10-08 Method for detecting and limiting breast carcinoma risk by a micronucleus test of binuclear cells

Country Status (5)

Country Link
EP (1) EP1549949B1 (en)
AT (1) ATE458197T1 (en)
AU (1) AU2003300462A1 (en)
DE (2) DE10246811B4 (en)
WO (1) WO2004034055A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100410368C (en) * 2005-07-19 2008-08-13 翁炳焕 Pretreating method for chromosome nuclear type analysis lymphocyte culture specimen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ943700A0 (en) * 2000-08-16 2000-09-07 Diatech Pty Ltd Micronucleus assay

Also Published As

Publication number Publication date
DE10246811B4 (en) 2005-12-29
AU2003300462A8 (en) 2004-05-04
WO2004034055A2 (en) 2004-04-22
DE10246811A1 (en) 2004-04-22
EP1549949B1 (en) 2010-02-17
ATE458197T1 (en) 2010-03-15
WO2004034055A3 (en) 2004-06-10
DE50312427D1 (en) 2010-04-01
EP1549949A2 (en) 2005-07-06

Similar Documents

Publication Publication Date Title
MXPA02006145A (en) Method for isolation of rna from formalinfixed paraffinembedded tissue specimens.
CN1977051B (en) Salivary mRNA profiling, biomarkers and related methods and kits of parts
WO1999042090A3 (en) Treating cancer
WO2003018751A3 (en) Apparatus and method for electroporation of biological samples
IL140550A (en) Methods for early diagnosis of carcinomas
EP0341904A3 (en) Method for predicting the effectiveness of antineoplastic therapy in individual patients
AU5376299A (en) Method, equipment and reagent for cell separation
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
AU5156096A (en) Improvements in or relating to sample processing
WO2004063704A3 (en) Vitamin d assay
MX2007004079A (en) Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment.
DE69733657D1 (en) SYSTEM FOR AVOIDING INTRADIALTIC SYMPTOMATOLOGY
EP1102988B8 (en) Method of determining the immune response activity of blood and test kit therefor
WO2000053728A3 (en) Method for cultivating cancer cells from human tissue and device for preparing tissue samples
WO2006025028A3 (en) Novel classification method of blood cells and tailor-made therapy and prevention based thereupon
WO2003014395A1 (en) Method of examining bronchial asthma
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
WO2001019956A3 (en) A method for isolation of prostatic epithelial cells from semen
WO2003069307A3 (en) Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer
WO2003040064A3 (en) Kits and methods for preparing cell samples optimized for dual staining
NO20011394L (en) Mammoglobin, a secreted breast-specific breast cancer protein
AU2003300462A1 (en) Method for detecting and limiting breast carcinoma risk by a micronucleus test of binuclear cells
AU1982799A (en) Novel potassium channel protein
SE8801426D0 (en) METHOD AND METHOD OF BLOOD TREATMENT
ES8501630A1 (en) In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase